Loading clinical trials...
Loading clinical trials...
This study will be conducted in two parts run in parallel. Part 1 of the study (Phase 1, randomized, double-blind, placebo-controlled, multiple ascending dose) will enroll healthy volunteers in 3 seq...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bond Biosciences
NCT04202965 · Hereditary Hemochromatosis
NCT03203850 · Hereditary Hemochromatosis
NCT00068159 · Hereditary Hemochromatosis
NCT05742035 · Hereditary Hemochromatosis, Hyperferritinemia
NCT03395704 · Hereditary Hemochromatosis
Clinical Research Unit
Sydney, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions